Choose the product architecture
Decide whether the brief is single-ingredient creatine, a flavored daily powder or a broader performance blend. Establish the intended serving and ingredient identity before choosing packaging. Each additional ingredient should solve a defined customer or formulation problem.
Evaluate the format, not just the label
For gummies, liquids or other alternative formats, ask how ingredient content and stability will be evaluated after processing and during storage. A successful bench sample is only one step. Agree testing methods and acceptance criteria with qualified partners before finalizing the commercial promise.
Make consistency part of the brief
Identify raw-material specifications, serving instructions, blend uniformity questions and packaging conditions. For a flavored powder, review dispersion and sensory performance using a consistent preparation method. For a multi-ingredient concept, distinguish what each component contributes to the intended positioning.
A USEFUL STARTING POINT
Bring these three decisions.
- Single-ingredient or blend strategy
- Target serving and preferred format
- Testing expectations and packaging constraints
PCG can scope concept definition, formulation and prototype work, sourcing, and the manufacturing handoff around your priorities. Deliverables, timing, testing and ownership terms are agreed for the project. Manufacturing is performed by the selected CDMO.
BEFORE WE BEGIN
Creatine formulation: your questions.
Can PCG help develop creatine gummies?
Yes, as a feasibility-led project. Serving size, piece count, processing, content testing and stability need to be reviewed before committing to a commercial formula.
Can we start with an unflavored creatine powder?
Yes. Simpler positioning can keep the development brief focused on material qualification, handling, packaging and a consistent serving experience.
Can creatine be combined with electrolytes?
The combination can be explored against the proposed serving, taste and customer use occasion. It should be evaluated as a finished formulation, not merely assembled from two existing labels.